DynamiCure Biotechnology
DynamiCure is seeking an experienced Medical Director to lead its clinical development in oncology, focusing on vascular normalization and tumor microenvironment programs. The role involves designing and communicating global clinical strategies, collaborating across various teams, and engaging with external stakeholders including regulatory authorities and key opinion leaders.
Headquarters
Waltham, Massachusetts, United States
Company Size
11-50 employees
Founded
2020
DynamiCure Biotechnology is a biotechnology company translating breakthrough immuno-normalization insights into a pipeline of innovative therapeutic antibody candidates with first-in-class and best-in-class potential. The company focuses on discovering and developing treatments for a broad array of cancers, autoimmune, and potentially other diseases. Headquartered in Waltham, MA, DynamiCure aims to revolutionize patient outcomes through its pioneering approach to drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for DynamiCure Biotechnology.
Medical Director, Clinical Science - Solid Tumor
Takeda Pharmaceutical Company Limited
Clinical Development Medical Director - Neuromuscular
Novartis
Medical Director, Clinical Development, Oncology (Prostate and Renal Cancers)
Regeneron Pharmaceuticals
Vice President, Clinical Development
Servier
Senior Medical Director, Oncology Clinical Development
Zailab
Clinical Data Management Director
Exelixis